All News about Corcept TherapeuticsVia Benzinga
Via Benzinga
Analyst Ratings for Corcept Therapeutics
April 04, 2023
Via Benzinga
Analyst Expectations for Corcept Therapeutics's Future
March 08, 2023
Via Benzinga
Via Benzinga
Via Benzinga
Corcept Therapeutics Initiates CATALYST Clinical Trial
March 28, 2023
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via Benzinga
Corcept Therapeutics Provides Miricorilant Clinical Development Update
December 08, 2022
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|